Influenza A: Unraveling the Mystery of H1N1 and H3N2 | #influenza
Influenza A: Unraveling the Mystery of H1N1 and H3N2 | #influenza
Challenges in Malaria Vaccine Development | #malaria Vaccine
Breakthrough Ideas for Parkinson’s Disease Treatment | #parkinson’s Disease
Pharmaceutical safety is an essential factor in the development of every medicament. It is essential to establish that an investigational product has antiviral activity at concentrations that can be achieved in vivo without inducing toxic effects to cells. Furthermore, in a cell culture model, the apparent antiviral activity of an investigational product can be the result of host cell death after exposure to the product. Thus, it is crucial to determine the cytotoxic potential of the formulation on the cell line used in the antiviral assays. https://antiviral.creative-dia....gnostics.com/cc50-ic
Plaque assay and TCID50 assay are helpful methods for determining viral titers. TCID50 assays are being used to determine the infectious titer of any such virus types, which can cause cytopathic effects (CPE, structural changes in a host cell resulting from viral infection) in tissue culture over a reasonable period of 5 to 20 days while cells in culture remain viable. https://antiviral.creative-dia....gnostics.com/TCID50-